Takeda GmbH, production site Oranienburg (full-cycle manufacturing)

The drug is used for the prevention and treatment of calcium and vitamin D deficiency in adults at risk. It can also be used as an adjunct to the main therapy for osteoporosis.

Dosage form: tablets, film-coated

ATC: A12AX

The drug is used for acute and chronic ischemic heart disease, as well as for the prevention of recurrent thrombosis. It may also be considered for primary prevention in patients with diabetes mellitus who are at high risk of cardiovascular disease.

Dosage form: tablets, film-coated

ATC: B01AC06

The drug is prescribed for acute and chronic ischemic heart disease.

Dosage form: tablets, film-coated

ATC: B01AC06

The drug is used for the symptomatic treatment of gastroesophageal reflux disease, long-term treatment and prevention of relapses of reflux esophagitis, as well as for adults for the prevention of gastric and duodenal ulcers caused by long-term use of anti-inflammatory drugs (NSAIDs).

Dosage form: tablets, enteric-coated

ATC: A02BC02

The drug is used for the treatment of reflux esophagitis, gastric and duodenal ulcers, as well as for the eradication of Helicobacter pylori bacteria (in combination with antibiotics). It is also prescribed for Zollinger-Ellison syndrome and other conditions accompanied by increased acidity.

Dosage form: tablets, enteric-coated

ATC: A02BC02

The drug is used for the treatment of erosive esophagitis (at all stages), for the relief of heartburn, and as maintenance therapy for erosive esophagitis in patients aged 12 years and older.

Dosage form: capsules, solid modified-release

ATC: A02BC06

The drug is used for the treatment of erosive esophagitis (at all stages), maintenance treatment of erosive esophagitis and relief of heartburn, as well as for the treatment of heartburn associated with symptomatic non-erosive gastroesophageal reflux disease.

Dosage form: capsules, solid modified-release

ATC: A02BC06